首页> 外文OA文献 >Basosquamous carcinoma - Treatment with Mohs micrographic surgery
【2h】

Basosquamous carcinoma - Treatment with Mohs micrographic surgery

机译:Basosquamous癌 - 莫氏显微手术治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Basosquamous carcinoma (BSC) is a rare tumor defined as a basal cell carcinoma (BCC) differentiating into squamous cell carcinoma (SCC). It is reported to have a high rate of recurrence with standard wide local excision. The aim of the current study was to report a large series of patients with BSC treated with Mohs micrographic surgery (MMS). METHODS: The prospective, multicenter case series included all patients in Australia treated with MMS for BSC, who were monitored by the Skin and Cancer Foundation Australia between 1993 and 2002. RESULTS: Most of the 178 tumors (95.6%) were located in the head and neck area. Recurrent tumors occurred in 47.8% of patients. The tumors were diagnosed initially as BCC in 87.4% and as SCC in 12.0% of patients. Perineural invasion was recorded in 7.9% of patients with data available. Most of these (69.0%) were previously recurrent tumors. Of 98 patients who completed a 5-year follow-up period after MMS, 4 (4.1%) had disease recurrence. CONCLUSIONS: The low 5-year disease recurrence rate of BSC with MMS emphasized the importance of margin-controlled excision using MMS.
机译:背景:基底鳞癌(BSC)是一种罕见的肿瘤,被定义为分化为鳞状细胞癌(SCC)的基底细胞癌(BCC)。据报道,采用标准的局部切除术具有较高的复发率。本研究的目的是报告接受Mohs显微外科手术(MMS)治疗的大量BSC患者。方法:该前瞻性,多中心病例系列研究包括澳大利亚皮肤病和癌症基金会在1993年至2002年间对澳大利亚所有接受MMS BSC治疗的患者。结果:178例肿瘤中的大多数(95.6%)位于头部和脖子区域。 47.8%的患者发生复发性肿瘤。最初被诊断为BCC的患者占87.4%,被诊断为SCC的患者占12.0%。有7.9%的患者记录了神经周围浸润,已有数据可用。其中大多数(69.0%)是先前复发的肿瘤。在MMS后完成5年随访的98位患者中,有4位(4.1%)复发了疾病。结论:伴有MMS的BSC的5年疾病低复发率强调了使用MMS进行切缘控制切除的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号